|
Volumn 350, Issue 6264, 2015, Pages 1031-1032
|
Could microbial therapy boost cancer immunotherapy?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;
IPILIMUMAB;
POLYSACCHARIDE;
PROGRAMMED DEATH 1 LIGAND 1;
VANCOMYCIN;
MONOCLONAL ANTIBODY;
BIOTA;
CANCER;
IMMUNE RESPONSE;
MICROBIAL ACTIVITY;
MODEL TEST;
RODENT;
TUMOR;
ADOPTIVE TRANSFER;
ADVANCED CANCER;
BACTEROIDALES;
BIFIDOBACTERIUM;
BURKHOLDERIALES;
CANCER IMMUNOTHERAPY;
CD8+ T LYMPHOCYTE;
CLOSTRIDIALES;
CLOSTRIDIUM DIFFICILE INFECTION;
DENDRITIC CELL;
DRUG EFFICACY;
HUMAN;
INTESTINE FLORA;
LUNG CANCER;
MELANOMA;
NONHUMAN;
PRIORITY JOURNAL;
SHORT SURVEY;
TUMOR GROWTH;
TUMOR IMMUNITY;
TUMOR MICROENVIRONMENT;
ANIMAL;
ANTAGONISTS AND INHIBITORS;
BACTEROIDES;
FEMALE;
IMMUNOLOGY;
MALE;
SKIN NEOPLASMS;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD274;
BACTEROIDES;
BIFIDOBACTERIUM;
CTLA-4 ANTIGEN;
FEMALE;
GASTROINTESTINAL MICROBIOME;
HUMANS;
MALE;
MELANOMA;
SKIN NEOPLASMS;
|
EID: 84948677086
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.aad7706 Document Type: Short Survey |
Times cited : (35)
|
References (14)
|